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MINI-ABSTRACT 
This national population-based cohort study suggests surgeon age ≥56 years is 2 
associated with increases in both short- and long-term mortality. Individual 
competency-based assessments may reduce the adverse effects of surgeon aging 4 
upon patient outcomes from highly physically and mentally demanding procedures 
such as esophagectomy.  6 
 
  8 
 3 
 
3 
STRUCTURED ABSTRACT (word count 238) 
Objective: It was hypothesized that patient survival improves with increasing 2 
surgeon age up to an age where it then decreases. 
Background: Experience, and physical and psychological abilities required for 4 
esophagectomy may change with increasing surgeon age.  
Methods: This population-based cohort study included all patients having undergone 6 
esophagectomy for esophageal cancer in Sweden in 1987-2010, with follow-up until 
2016. Risk-adjusted cumulative sum (RA-CUSUM) analysis was performed to 8 
estimate the relation between surgeon age and 90-day mortality, all-cause and 
disease-specific 5-year mortality. Change-points in surgeon age identified by the RA-10 
CUSUM were then analyzed in relation to mortality using multivariable Cox 
regression, providing hazard ratios (HRs) with 95% confidence intervals (CIs), 12 
adjusted for age, sex, comorbidity, tumor stage, tumor histology, neoadjuvant 
therapy, surgeon volume, and calendar year. 14 
Results: Among 139 surgeons performing 1761 esophagectomies, RA-CUSUM 
analysis of 90-day mortality showed change-points at 43 years (downward 16 
deflection) and at 56 years (upward deflection). Both all-cause and disease-specific 
5-year mortality had corresponding change-points at 52 years and 56 years. 18 
Compared to surgeon age 52–55 years, surgeon age ≤51 years was associated with 
increased 90-day mortality (HR=1.71, 95%CI 1.01–2.90) and 5-year all-cause 20 
mortality (HR=1.21, 95%CI 1.02–1.43), and surgeon age ≥56 years showed increased 
90-day mortality (HR=2.38, 95%CI 1.38–4.13), 5-year all-cause mortality (HR=1.29, 22 
95%CI 1.08–1.55), and disease-specific 5-year mortality (HR=1.18, 95%CI 1.01–1.42).  
 4 
 
4 
Conclusions: Surgeon age ≤51 and ≥56 years may increase short- and long-term 
mortality following esophagectomy for cancer.  2 
 
 4 
  
 5 
 
5 
INTRODUCTION 
Esophagectomy is a critical component in the curative treatment of most esophageal 2 
cancers. However, this is a technically demanding and time-consuming procedure 
with higher rates of mortality and morbidity than most other surgical procedures [1–4 
3]. We have previously highlighted the influence of surgeon volume and surgical 
proficiency gain upon survival from esophageal cancer [4–6], demonstrating the high 6 
prognostic value of surgical skill and performance during esophagectomy. The 
physical and psychological abilities required for this operation may change with 8 
increasing surgeon age. Government regulatory bodies often specify the retirement 
age threshold with a primary emphasis on balancing the workforce, and thus 10 
physicians in medical and surgical specialties have a similar retirement age, despite 
the high technical demands for complex surgery [7,8]. As individual surgeons age 12 
their risk-taking behaviour and levels of confidence might change, which may be 
reflected in surgical practice [9,10]. There is limited evidence of the role of surgeon 14 
age on patient outcome from surgery. One previous publication suggested that older 
surgeon age may negatively influence in-hospital mortality from selected 16 
procedures, including pancreatectomy, coronary artery bypass grafting, and carotid 
endarterectomy [11]. No previous study has examined the influence of surgeon age 18 
upon long-term prognosis following any type of cancer surgery. It was hypothesized 
that the prognosis after esophageal cancer surgery, independent of other prognostic 20 
factors, improves with increasing surgeon age up to a certain point as the surgeon 
gains experience, after which the prognosis declines due to surgeon age-related 22 
physical and psychological factors. To test this hypothesis, a Swedish nationwide 
cohort study with adjustment for potential confounders was conducted. 24 
 6 
 
6 
METHODS 
Study design 2 
The comprehensive and well-established nationwide Swedish cohort study utilized 
for this study has been described in detail elsewhere [4,5]. In brief, the cohort 4 
included 98% of all patients with esophageal cancer (adenocarcinoma or squamous 
cell carcinoma) who underwent esophagectomy between 1987 and 2010 in Sweden, 6 
with follow-up until May 31, 2016. Patients with esophageal cancer were identified 
from the Swedish Cancer Registry, a registry with 98% nationwide coverage of 8 
esophageal cancer [12]. Patients who underwent esophagectomy were identified 
from the Swedish Patient Registry, which has an excellent completeness and high 10 
positive identification value (99.6%) for esophageal surgery [13]. The Patient Registry 
also provided data pertaining to patient medical comorbidities [14]. The 12 
comorbidities were classified according to the most up-to-date version of the well-
validated Charlson comorbidity score system, where the esophageal cancer diagnosis 14 
was not counted [15]. Medical records containing operation notes and 
histopathological reports were retrieved from all Swedish hospitals where 16 
esophageal cancer surgery was performed during the study period. This clinical data 
collection from the medical records was facilitated through our nationwide Swedish 18 
clinical network, established in the mid-1990s [16]. The data retrieval from the 
medical records followed a predefined study protocol to ensure uniformity, and the 20 
reviewers were blinded to the outcome of the patients. Data concerning 
neoadjuvant therapy, names of the surgeons, date of the operation, tumor 22 
pathological stage, and histological subtype were obtained from these individual 
patient records. The high accuracy of histopathological review of two independent 24 
 7 
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researchers has been previously described [17]. Neoadjuvant therapy was used 
mainly in more recent years, and when used it was typically a combination of 2 
chemotherapy and radiotherapy. Tumor stage was classified according to the TNM 
classification of the Union Internationale Contre le Cancer (UICC) [18]. Open 4 
transthoracic esophagectomy with intrathoracic anastomosis was the dominating 
procedure (95%). The personal identity number, assigned to each Swedish resident 6 
at birth or immigration, enabled linkage of all participants’ data between registries 
and identification of each patient´s medical records. The Regional Ethical Review 8 
Board in Stockholm, Sweden approved the study.  
 10 
Exposure 
The age of the surgeon at the time of esophagectomy for each patient was the study 12 
exposure. This age was calculated from the date of birth of each surgeon and the 
date of each operation. Surgeon date of birth was identified from the Swedish 14 
Matriculation Registry (“Läkarmatrikeln”), which includes all physicians in Sweden. 
Date of surgery was determined from the operation charts. A previously developed 16 
algorithm was used to assign the surgery to the most experienced surgeon whenever 
more than one surgeon conducted the esophagectomy [4]. First, the primary 18 
surgeon’s chronological number of surgeries was calculated for each year over the 
study period. Thereafter, the surgeon with the highest chronological number of 20 
surgeries at the index operation was considered responsible for the surgery.  
 22 
Outcomes  
 8 
 
8 
The outcomes were all-cause 90-day and 5-year mortality, as well as disease-specific 
5-year mortality, all counted from the date of surgery. The nationwide Swedish 2 
Causes of Death Registry provided accurate data for date and causes of death. This 
Registry has 100% coverage. If a diagnosis of esophageal cancer was listed as a cause 4 
of death in this registry, this mortality was defined as disease-specific. 
 6 
Statistical analysis  
Risk-adjusted cumulative sum (RA-CUSUM) curve analysis 8 
RA-CUSUM curves were created to define the proficiency-gain curve for 90-day, 5-
year all-cause and disease-specific mortality following esophagectomy [19]. Risk 10 
prediction models using logistic regression were employed to calculate the predicted 
probability of each outcome in each case (the expected survival/mortality). The 12 
curves plot the cumulative difference between the observed and expected mortality 
according to the risk-adjustment model. This was calculated using the CUSUM 14 
equation Si=Si-1+(Σi- ΣR); S0=0: Si is the cumulative sum, Σi the sum of events at 
surgeon age i, and ΣR the sum of expected events at surgeon age i. On the basis of 16 
this equation the curve increases if the observed mortality exceeds the expected 
mortality (downward deflection), and vice versa (upward deflection). Change points 18 
were identified as the maximal deflection of the curve from 0. The statistical 
significance of the change points was analyzed by comparing mortality before and 20 
after the change points, using a p-value of less than 0.05 as the level of significance. 
Potential confounding factors included in the models were age (continuous variable), 22 
sex (male or female), comorbidity (Charlson comorbidity score 0, 1 or ≥2), 
pathological tumor stage (0 or I, II, III or IV), tumor histology (adenocarcinoma or 24 
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squamous cell carcinoma), and use of neoadjuvant therapy (yes or no). Potential 
confounding factors (surgeon volume and year of surgery) with a strong correlation 2 
with the exposure (surgeon age) were not included in this risk adjustment, which is 
standardized methodology for RA-CUSUM [5]. However given the clinical importance 4 
of distinguishing surgeon volume and year of surgery from surgeon age, they were 
included in the subsequent Cox regression analyses (presented below).  6 
 
Mann-Whitney U test and Chi-square test 8 
The patients were categorized based on the change points in the surgeon age 
identified in the RA-CUSUM curve analysis. When comparing patient and tumor 10 
characteristics, the continuous variable, patient age, was analyzed using the Mann-
Whitney U test, while the binary variables, patient sex, comorbidity, tumor 12 
characteristics, utilization of neoadjuvant therapy, reoperation, resection margins 
and mortality, were compared using the Chi-square test. The level of statistical 14 
significance was set at a p-value of less than 0.05. 
 16 
Kaplan-Meier analysis 
Kaplan-Meier survival curve analysis was performed for 5-year all-cause and disease-18 
specific mortality based on the change points identified in the RA-CUSUM curve 
analysis. When performing the log rank test, a threshold of significance was set at a 20 
p-value of less than 0.05.  
 22 
Cox regression analysis 
 10 
 
10 
Finally, the change-points in surgeon age identified by the RA-CUSUM curve analysis 
were analyzed in relation to the mortality outcomes also using a multivariable Cox-2 
proportional hazards model, providing hazard ratios (HRs) with 95% confidence 
intervals (CIs). The HRs were adjusted for all six potential confounding factors listed 4 
above (with the same categorization) with the addition of cumulative surgeon 
volume of esophagectomies during study period (≤16 or >16) and calendar period of 6 
surgery (year 1987–1994, 1995–2002, or 2003–2010). Cumulative surgeon volume 
was categorized as ≤16 or >16 esophagectomies based upon the median throughout 8 
the study period.  
 10 
RA-CUSUM curves were computed using Excel (Excel for Mac 2011, version 14.1.4, 
Microsoft Corporation). For the Mann-Whitney, Chi-square, Kaplan-Meier (with log-12 
rank testing), and Cox regression analysis the SPSS software was used (Statistical 
Package for the Social Sciences software, Version 22, SPSS Chicago [IL], USA).  14 
 
  16 
 11 
 
11 
RESULTS 
Patients and surgeons 2 
The entire cohort included 1820 patients. After excluding 59 patients (3.2%) without 
the surgeon’s age available, 1761 patients remained for final analysis. There was a 4 
total of 139 surgeons performing the operations. The median number of 
esophagectomies performed per surgeon was 16 (range 1-262; interquartile range 6 
6–46).  
 8 
Surgeon age and change points in mortality 
The RA-CUSUM analysis of surgeon age in relation to 90-day mortality showed two 10 
change-points, one at 43 years (downward deflection) and another at 56 years 
(upward deflection) (Figure 1). The association between surgeon age and 5-year all-12 
cause mortality and 5-year disease-specific mortality both showed a first change-
point at 52 years (downward deflection) and a second change-point at 56 years 14 
(upward deflection) (Figures 2a and 2b). The patients were divided into three groups 
based upon the change-points for 5-year mortality in surgeon age; ≤51 (patients = 16 
946), 52–55 (patients = 291), or ≥56 (patients = 524) years. There were no major 
differences between these groups of patients regarding age, sex, comorbidity, tumor 18 
stage, tumor histology, utilization of neoadjuvant therapy, reoperation rates, or non-
radical (R1/2) resection margins (Table 1). As expected, there was a greater 20 
representation of higher volume surgeons in the older surgeon age groups.  
 22 
Ninety-day mortality 
 12 
 
12 
Change-points in surgeon age at 52 years were associated with a reduction in 90-day 
mortality from 12.1% to 6.9% (p=0.013), and an increase in 90-day mortality at 56 2 
years from 6.9% to 12.8% (p=0.009). Cox regression analysis demonstrated that 
compared to surgeon age between 52–55 years (reference category), surgeon age 4 
≤51 years (adjusted HR=1.71, 95%CI 1.01–2.90) and surgeon age ≥56 years (adjusted 
HR=2.38, 95%CI 1.38–4.13) were associated with increased 90-day mortality (Table 6 
2).  
 8 
Five-year all-cause mortality  
Change-points in surgeon age at 52 years were associated with a reduction in 5-year 10 
all-cause mortality from 79.0% to 69.1% (p<0.001), and an increase at 56 years from 
69.1% to 76.7% (p=0.017). The differences in the Kaplan-Meier curves with log-rank 12 
test were statistically significant (p=0.004) for the three surgeon age groups 
identified in the RA-CUSUM analysis (Figure 3a). Using surgeon age between 52–55 14 
years as the reference category, surgeon age ≤51 years (HR=1.21, 95%CI 1.02–1.43) 
and surgeon age ≥56 years (HR=1.29, 95%CI 1.08–1.55) were associated with 16 
increased 5-year all-cause mortality.  
 18 
Five-year disease-specific mortality  
Changes in 5-year disease-specific mortality were not statistically significant 20 
(p=0.070), but followed the same trend in decreasing the mortality in the surgeon 
age group 52–55 years (60.8%) compared with the ≤51 group (67.4%) and the ≥56 22 
surgeon age group (63.4%). The Kaplan-Meier curves showed a statistical 
significance in the log-rank test (p=0.021) as depicted in Figure 3b. Compared to 24 
 13 
 
13 
surgeon age 52–55 years (reference category), surgeon age ≤51 years showed no 
statistically significant increase (HR=1.14, 95% CI 0.96–1.36), while surgeon age ≥56 2 
years was associated with an increased 5-year disease-specific mortality (HR=1.18, 
95% CI 1.01–1.42). 4 
 
 6 
 
 8 
   
  10 
 14 
 
14 
DISCUSSION 
The results of this study support the hypothesis under investigation, i.e. that the 2 
prognosis after esophageal cancer surgery, independent of other prognostic factors, 
improves with increasing surgeon age up to a certain point after which the prognosis 4 
declines. Among younger surgeons, short-term and long-term mortality are higher as 
the surgeons gain proficiency, paralleling the results of our previous study [5]. Then, 6 
highest surgical competence is achieved between 52 and 56 years of surgeon age. 
Finally, and most interestingly, both short and long-term mortality are again 8 
increased at a surgeon age from 56 years onwards.  
  10 
The population-based design with nearly complete inclusion of all eligible patients in 
Sweden is a main strength of the study, along with the complete follow-up of all 12 
patients for at least 5 years, and the adjustment for relevant confounding factors, 
including surgeon volume. The cohort has high accuracy in the identification of 14 
patients undergoing esophagectomy for cancer of the esophagus. The relevant data 
were collected based on a predefined study protocol from extensive review of 16 
medical records and nationwide registries, which made it possible to have unbiased 
and detailed information on exposures, outcomes, and covariates. There are also 18 
limitations. The external validity (generalizability) of these findings in another 
country with a different healthcare structure and surgical training program remains 20 
unknown. The median number of esophagectomies per surgeon was low at 16 
during the study period, therefore especially for the applicability of these results to 22 
high annual volume surgeons remains undetermined by the present study. The study 
period is long and therefore it is conceivable that developments in other areas over 24 
 15 
 
15 
time, e.g. clinical staging, addition of neoadjuvant therapy regimens, and enhanced 
recovery protocols, may have contributed to the improvement in short- and long-2 
term outcomes. However, year of surgery was adjusted for in the regression model, 
with the influence of surgeon age persisting. There may be additional unmeasured 4 
factors, e.g. new surgical techniques and equipment that may have been used less 
frequently by older surgeons, but any such differences are not confounders, but 6 
rather included as part of the causal pathway for the association between surgeon 
age and patient prognosis.   8 
 
A previous retrospective study from the United States suggested that surgeon age 10 
did not affect short-term mortality from esophagectomy, however this analysis failed 
to adjust for tumor stage, use of neoadjuvant therapy, and patient medical 12 
comorbidities, and data on long-term survival were not available [11]. The most 
important finding from the present study is that surgeon age ≥56 years appears to be 14 
associated with an increase in patient short- and long-term mortality, paralleling 
results seen in with younger surgeon age during the early part of their proficiency 16 
gain curve [5]. This is unlikely to be an issue associated with changes in patient 
selection, surgeon volume, or year of surgery as the influence of surgeon age 18 
persisted when these factors were adjusted for in the analysis. With age, surgeons 
gain a greater experience and competence with increasing cumulative surgical 20 
volume. However, as with any demanding and time-consuming procedural activity, 
technical skill and the ability to concentrate for long periods are critical to 22 
performing esophagectomy, and both of these may decrease with advancing 
surgeon age.  24 
 16 
 
16 
 
Retirement age is most commonly based on the theory that a worker’s productivity 2 
declines significantly after age 65. However, some occupations that require high 
levels of physical or mental skill (e.g. airline pilots) often have an earlier retirement 4 
age, and retirement might be individual-specific depending on abilities during regular 
physical and psychological tests [20]. Clearly there is a range of surgeon’s physical 6 
and psychological ability and some surgeons may perform esophagectomy well past 
the age of 56 years with excellent outcomes for their patients. However, these first 8 
findings of strong associations between older surgeon age and worse long-term 
survival following esophagectomy for cancer are intriguing, although more studies 10 
from other populations are needed before causality can be claimed.  
 12 
The RA-CUSUM curves (Figure 2a and b) show a continuous improvement in 
mortality rates until 52, during the period of initial learning, then an average level of 14 
performance is reached with some further improvement 52 – 56, and then an actual 
deterioration in mortality rates beyond 56. Thus the period of optimal performance 16 
between 52 – 56 years appears relatively short. However, if an analogy is drawn to 
other technical performance professions such as athletes or musicians, the level of 18 
optimal performance is similarly short, when the professional has sufficient expertise 
and is at the peak of their technical abilities to maximize their level of performance. 20 
 
If the results of this study are confirmed they do suggest at a group level there may 22 
be a need for a competency-based assessment as surgeons advance in age past 56 
years in order to minimize patient harm. Continuous evaluation of surgeon 24 
 17 
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outcomes through a process of national audit is one potential mechanism often 
utilized to identify a decline in surgical performance [21,22]. However, to identify a 2 
measurable change in surgeon performance, patient outcomes will suffer, which 
ethically is unacceptable. A more robust method may be individual competency-4 
based assessments with human reliability analysis [23–25], which may identify 
changes in operative performance before such patient harm occurs.  6 
 
In conclusion, this first study to evaluate changes in mortality as surgeons age 8 
increases in performing esophagectomy for cancer indicates that surgeon age ≤51 
and ≥56 years is associated with increases in both short- and long-term mortality. 10 
These results persisted with adjustment for confounders, indicating an independent 
prognostic role of surgeon age.   12 
 18 
 
18 
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FIGURE LEGENDS 
Figure 1. RA-CUSUM curve for 90-day all-cause mortality, showing change-points at 2 
surgeon ages of 43 (downward deflection) and 56 years (upward deflection).  
 4 
Figure 2a. RA-CUSUM curve for 5-year all-cause mortality, showing change-points at 
surgeon ages of 52 (downward deflection) and 56 years (upward deflection).  6 
 
Figure 2b. RA-CUSUM curve for 5-year disease-specific mortality, showing change-8 
points at surgeon ages of 52 (downward deflection) and 56 years (upward 
deflection).  10 
 
Figure 3a. Kaplan-Meier survival curve analysis for 5-year all-cause mortality and the 12 
three surgeon age groups; ≤51, 52–55, and ≥56 years (chi-square=11.29, p=0.004).  
 14 
Figure 3b. Kaplan-Meier survival curve analysis for 5-year disease-specific mortality 
and the three surgeon age groups; ≤51, 52–55, and ≥56 years (chi-square=7.70, 16 
p=0.021).  
 18 
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